Industry Trend

Site Sections


Menu













© 2023. All Rights reserved.

Overview for ABBOTT LABORATORIES

All Data per May 26, 2023

Industry:

Medical Devices

Last Close:

102.87 USD

Expected Dividend:

1.98 %

Payoffs per Year:

4
Business Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Menière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.


Competitors View

Ordering

ABBOTT LABORATORIES

USA
1.0 2.06%
1.98%
10.51% 3.03% 1.0 2.5
-26.91%
33.03 11.44% 49.58 1.0

MEDTRONIC

USA
1.01 2.17%
3.54%
8.1% 2.86% 1.0 0.57
-33.65%
48.36 6.2% 57.95 2.0

STRYKER

USA
1.15 1.23%
1.12%
10.62% 1.82% 1.0 8.82
-8.57%
30.24 9.33% 42.96 3.0

ECKERT ZIEGLER STRAHLEN- UND MEDIZINTECHNIK

GER
1.03 1.17%
1.15%
18.75% 2.55% 0.5 5.61
-53.62%
23.26 5.72% 51.25 4.0

STRATEC

GER
0.81 1.15%
1.68%
2.44% 1.17% 1.0 0.73
-58.64%
57.45 37.81% 56.65 5.0

SMITH NEPHEW

GBR
1.08 2.19%
3.06%
10.44% 3.21% 1.0 0.36
-39.41%
38.19 -26.0% 52.77 6.0

ZIMMER BIOMET

USA
1.09 0.83%
0.75%
0.0% 0.76% -0.5 0.84
-19.96%
13.82 -7.88% 57.09 7.0

DRÄGERWERK

GER
1.03 0.33%
0.42%
0.0% 0.3% 1.0 -0.31
-56.02%
50.87 -5.28% 42.47 8.0


Information for ABBOTT LABORATORIES

Yield Triangle

Dividend & Close

Dividend Close Div.-Yield
Year
2023 2.04 102.87 1.98
2022 1.88 109.79 1.71
2021 1.80 140.74 1.28
2020 1.44 109.49 1.32
2019 1.28 86.86 1.47
2018 1.12 71.09 1.58
2017 1.06 57.07 1.86
2016 1.04 38.41 2.71
2015 0.96 44.91 2.14
2014 0.88 45.02 1.95
2013 0.56 38.33 1.46

Fundamentals

Chart